AAAdetunji Olawale Adediran

Adetunji Olawale Adediran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adetunji Olawale Adediran has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cost-Effectiveness of Fixed-Dose Combination Polypills for Secondary Cardiovascular Disease Prevention: A Systematic Review

    by Obiageri Ihuarulam Okeoma, Adetunji Olawale Adediran, David O. Adeoti, Comfort Ohunene Matthew

    Background: Cardiovascular disease remains a leading cause of global morbidity and mortality, and long-term secondary prevention is often limited by poor adherence, pill burden, treatment costs, and health system barriers. Fixed-dose combination polypills may simplify treatment by combining multiple cardiovascular medicines into a single formulation, thereby improving adherence and reducing recurrent cardiovascular events. Objective: This systematic review evaluated the cost-effectiveness of fixed-dose combination polypills compared with usual care, standard therapy, or separate monocomponents for secondary cardiovascular disease prevention across different healthcare and income settings. Methods: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. PubMed, Dimensions AI, ScienceDirect, and the Tufts Cost-Effectiveness Analysis Registry were searched for studies published between January 2015 and December 2025. Eligible studies included economic evaluations involving adults with established cardiovascular disease and reporting incremental cost-effectiveness ratios, cost per quality-adjusted life year, cost per disability-adjusted life year, cost savings, or related economic outcomes. Reporting quality was assessed using the Consolidated Health Economic Evaluation Reporting Standards checklist. Results: Fourteen records were included, comprising 13 full or partial economic evaluations and one Delphi consensus study with policy-relevant contextual interpretation. Most studies were conducted in high-income countries, particularly Spain, while evidence from low- and middle-income countries was limited. Fixed-dose combination polypills were generally reported as cost-effective or cost-saving, mainly driven by improved medication adherence, reduced pill burden, and prevention of recurrent cardiovascular events. Findings were also influenced by methodological factors such as analytic perspective and time horizon adopted across studies. Conclusion: Fixed-dose combination polypills may offer economic value for secondary cardiovascular disease prevention, but broader implementation should be guided by local cost-effectiveness, affordability, budget impact, and real-world evidence, especially in low- and middle-income countries.

  • Pandemic Preparedness, Resilience, and Recovery in Health Systems

    by Kehinde Oluwafemi Fabiyi, Jennifer Tettey, Peter Aduvie Josiah, Akamien Joanna, Olawale Adetunji Adediran, Oluwatomilayo Oluwayinka Fasesin, Leo Tata

    Pandemics and public health emergencies expose vulnerabilities in healthcare systems, disrupt other sectors that provide essential services, and exacerbate socioeconomic inequalities among populations. This narrative review assesses components of pandemic preparedness, health system resilience, and strategies of recovery from a global health crisis. Lessons from COVID-19 and other previous pandemics—such as the importance of early warning systems, robust surveillance, adaptive workforce deployment, sustainable supply chains, and strong governance are considered. In addition to preparation for and management of a pandemic, a health system must not only absorb shock to be considered resilient, but also adapt and transform to deal with a crisis. This healthcare transformation can be achieved through adopting digital health information systems, new methods of healthcare financing, and active involvement of local communities. The importance of protecting essential health services, such as immunization, maternal healthcare, and management of patients with chronic diseases, is highlighted. The review also addresses the disproportionate impact of these health crises on vulnerable populations such as people of low socioeconomic status, the elderly, and displaced people. Finally, recommendations are provided on how to strengthen global health security by strengthening primary health care, ensuring equitable distribution of resources, and investing in local manufacturing of health products and in digital health information systems. Building back better in the aftermath of a pandemic will require sustained political will and, most importantly, international solidarity and a fundamental shift from a health crisis reaction model to a model of equity-centered preparedness and proactiveness. Investment in primary health care, digital health technologies, local manufacturing of health products and emergency preparedness are key to future health security. Strong pandemic preparedness and resilience require sustained political commitment, global solidarity and an equity-oriented proactive approach to protect the world’s population in the face of a health crisis.